Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Stomach Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Hematologic Neoplasms 1 FGFR1 Gene Amplification 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 53 Cisplatin 52 Fluorouracil 50 Capecitabine 48 pembrolizumab 39 Leucovorin 31 Docetaxel 26 Trastuzumab 23 Paclitaxel 20 Irinotecan 20 Ramucirumab 13 Bevacizumab 12 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 S 1 (combination) 7 Nivolumab 7 Epirubicin 7 Carboplatin 6 olaparib 5 Platinum 5 Everolimus 5 Sunitinib 4 Mitomycin 4 trastuzumab deruxtecan 3 lenvatinib 3 epacadostat 3 bemarituzumab 3 apatinib 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × AZD4547 × Clear all

NCT01457846 2017-03-07

SHINE

AstraZeneca

Phase 2 Terminated

960 enrolled 13 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡